Home › Funds › Kiltearn Partners LLP › MDT
Kiltearn Partners LLP position in MDT
MEDTRONIC PLC · Health Care
Kiltearn Partners LLP reported holding 137,008 shares of MDT (MEDTRONIC PLC) in its Q3 2026 13F filing — a position valued at US$11.8M, representing 2.85% of its reported portfolio and ranking #13 among its reported holdings. Kiltearn Partners LLP has disclosed MDT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Kiltearn Partners LLP's MDT position evolved
Kiltearn Partners LLP first disclosed a stake in MDT in Q3 2023 at 241,100 shares (US$18.9M). The position peaked in Q4 2023 at 396,061 shares, worth US$32.6M. Across 13 filings, Kiltearn Partners LLP increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 137,008 shares valued at US$11.8M — a reduction of -5,780 shares quarter over quarter.. Notable position changes include a 64% increase in Q4 2023 (shares rose 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 241.10K | $18.89M | New |
| Q4 2023 | 396.06K | $32.63M | Add |
| Q1 2024 | 333.86K | $29.05M | Reduce |
| Q2 2024 | 359.76K | $28.32M | Add |
| Q3 2024 | 327.86K | $29.52M | Reduce |
| Q4 2024 | 296.26K | $23.67M | Reduce |
| Q1 2025 | 251.56K | $22.61M | Reduce |
| Q2 2025 | 232.76K | $20.29M | Reduce |
| Q3 2025 | 216.56K | $20.63M | Reduce |
| Q4 2025 | 180.76K | $17.36M | Reduce |
| Q1 2026 | 149.56K | $12.96M | Reduce |
| Q2 2026 | 142.79K | $11.17M | Reduce |
| Q3 2026 | 137.01K | $11.82M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDT and 13F data
MDT (MEDTRONIC PLC) is a Health Care company. 20 other funds we track also report a position in MDT — the largest reported positions include MFS Investment Management (US$2.56B), Deutsche Bank AG (US$1.55B), First Eagle Investment Management (US$1.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDT
- MFS Investment Management 18.09M sh · $2.56B · Q3 2026
- Deutsche Bank AG 18.00M sh · $1.55B · Q3 2026
- First Eagle Investment Management 13.95M sh · $1.20B · Q3 2026
- Arrowstreet Capital 13.85M sh · $1.20B · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 12.23M sh · $1.06B · Q3 2026
More on Kiltearn Partners LLP
FAQ
How long has Kiltearn Partners LLP held MDT?
Kiltearn Partners LLP has disclosed MDT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Kiltearn Partners LLP's current position in MDT?
As of Q3 2026, Kiltearn Partners LLP holds 137.01K shares of MDT (MEDTRONIC PLC), valued at $11.82M, representing 2.85% of its reported portfolio and ranking #13.
Has Kiltearn Partners LLP been buying or selling MDT?
In the latest 13F filing (Q3 2026), Kiltearn Partners LLP reduced its position in MDT. The position peaked in Q4 2023 at 396.06K shares.
Which other funds hold MDT?
Other major institutional holders of MDT include MFS Investment Management, Deutsche Bank AG, First Eagle Investment Management, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.